Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$3.28 - $6.42 $245,501 - $480,524
-74,848 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$5.16 - $7.14 $107,715 - $149,047
-20,875 Reduced 21.81%
74,848 $465,000
Q4 2021

Feb 14, 2022

BUY
$6.37 - $8.18 $62,661 - $80,466
9,837 Added 11.45%
95,723 $675,000
Q3 2021

Nov 12, 2021

BUY
$6.98 - $8.47 $221,259 - $268,490
31,699 Added 58.5%
85,886 $599,000
Q2 2021

Aug 06, 2021

BUY
$5.44 - $8.4 $294,777 - $455,170
54,187 New
54,187 $451,000
Q3 2018

Nov 08, 2018

SELL
$5.0 - $6.65 $615 - $817
-123 Closed
0 $0
Q2 2018

Aug 03, 2018

SELL
$4.2 - $5.95 $5,292 - $7,497
-1,260 Reduced 91.11%
123 $1,000
Q1 2018

May 11, 2018

BUY
$3.3 - $5.15 $1,686 - $2,631
511 Added 58.6%
1,383 $7,000
Q4 2017

Feb 08, 2018

BUY
$3.08 - $3.8 $421 - $520
137 Added 18.64%
872 $3,000
Q3 2017

Nov 06, 2017

BUY
$2.7 - $3.75 $1,984 - $2,756
735
735 $3,000

Others Institutions Holding HBIO

About HARVARD BIOSCIENCE INC


  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $113M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.